Saltar al contenido principal
Elsevier

Curcumin-Based Nanomedicines as Cancer Therapeutics

  • 1 Edición - 21 de febrero de 2024
  • Última edición
  • Editores: Amirhossein Sahebkar, Prashant Kesharwani
  • Idioma: Inglés

Curcumin-based Nanomedicines as Cancer Therapeutics presents a consistent and thorough overview of nanocurcumin applications in cancer treatments. It brings together the novel ap… Leer más

Descripción

Curcumin-based Nanomedicines as Cancer Therapeutics presents a consistent and thorough overview of nanocurcumin applications in cancer treatments. It brings together the novel applications of nanocurcumin in biological milieu as well as helps readers to define the major gaps in knowledge that can lead to significant scientific discoveries.

Nanocurcumin has been widely explored for the treatment of various cancers; however, the scientific literature is inconsistent in style and structure and scattered across many sources. By providing an explicit account on vital aspects on nanocurcumin-based anticancer delivery approaches and discussing the perspectives of the technologies explored so far based upon the findings outlined, the book offers updated and in-depth knowledge on the topic in one single source written by global leading experts.

In addition, the book aims to stimulate the interest of the academic researchers, industrial scientists, businessmen, and young scholars to address key multidisciplinary challenges faced by nanotechnologists to foster the desired collaboration among biologists, chemists, physicists, engineers, and clinicians to find proper and efficient new cancer treatments.

Puntos claves

  • Discusses the complete journey of curcumin delivery from fundamental to most recent anticancer applications using nanotechnology
  • Provides in-depth knowledge on novel anticancer application of nanocurcumin in biological milieu
  • Presents reliable and updated information for researchers on nanocurcumin-based anticancer targeted drug delivery

De interès para

Graduate students and researchers in cancer research and nanotechnology, Graduate students and researchers in pharmaceutical related disciplines, medical doctors, oncologists

Índice

Part-A: Curcumin: Introduction, structure, and physicochemical attributes

1. Curcumin: historical background, introduction, structure, and physicochemical attributes

2. Curcumin as a pharmaceutical leader

3. Chemical structure and molecular targets of curcumin for cancer therapy

4. Structural features of curcumin and its effects on cancer-related signaling pathways

5. An overview of cellular, molecular, and biological aspect(s) of curcumin in cancer

Part-B: Smart drug delivery approaches for curcumin delivery in cancer therapy

6. Curcumin-drug conjugate-based drug delivery as cancer therapeutics

7. Curcumin microcapsule-based drug delivery as cancer therapeutics

Part-C: Recent advances and regulatory aspects of gold nanoparticles

8. Nanoemulsion-based curcumin delivery systems as cancer therapeutics

9. Micelle-based curcumin delivery systems as cancer therapeutics

10. Liposome-based curcumin delivery systems as cancer therapeutics

11. Inorganic nanoparticle-based curcumin delivery as cancer therapeutics

12. PLGA nanoparticle-based curcumin delivery as cancer therapeutics

13. Polymersomes-based curcumin delivery as cancer therapeutics

Part-D: Recent advances in nanocurcumin delivery in cancer therapy

14. Biopolymer-based formulations for curcumin delivery toward cancer management

15. Nanohybrid drug delivery approach as a novel opportunity for curcumin delivery in cancer

16. Codelivery of curcumin and siRNA as anticancer therapeutics

Part-E: Challenges and future perspectives of nano-curcumin drug delivery

17. Challenges associated with nanocurcumin anticancer drug delivery systems

18. Curcumin-loaded nanoparticles used for in vivo cancer models: an approach about their physicochemical properties and mechanism of action

19. Clinical trials, patents, and marketed products of nanocurcumin-based anticancer drug delivery systems

Detalles del producto

  • Edición: 1
  • Última edición
  • Publicado: 21 de febrero de 2024
  • Idioma: Inglés

Sobre los editores

AS

Amirhossein Sahebkar

Dr. Amirhossein Sahebkar received his PharmD and PhD (in Medical Biotechnology) degrees from the Mashhad University of Medical Sciences (MUMS; Mashhad, Iran). His research focuses on the investigation of novel natural products for the management of severe cardiometabolic disorders. He has conducted numerous research projects dealing with basic, experimental, and clinical research on curcuminoids.
Afiliaciones y experiencia
Biotechnologist and Associate Professor of Medical Biotechnology, Mashhad University of Medical Sciences, Iran

PK

Prashant Kesharwani

Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing.

Afiliaciones y experiencia
Dr. Harisingh Gour Vishwavidyalaya University, India

Ver libro en ScienceDirect

Lee Curcumin-Based Nanomedicines as Cancer Therapeutics en ScienceDirect